Cardiovascular Effects of Cannabidiol: From Molecular Mechanisms to Clinical Implementation
International Journal of Molecular Sciences · 01.10.2025 · 26 (19) · 9610
DOI: 10.3390/ijms26199610 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.10.2025. Verfasst von Hrvoje Urlić und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital of Split, 21000 Split, Croatia. Hauptthemen laut MEDLINE: Cannabidiol, Cardiovascular Diseases, Cardiovascular System. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cannabidiol (CBD) and other phytocannabinoids are gaining attention for their therapeutic potential in cardiovascular disease (CVD), the world’s leading cause of death. This review highlights advances in understanding the endocannabinoid system, including CB1 and CB2 receptors, and the mechanisms by which CBD exerts anti-inflammatory, antioxidative, vasoprotective, and immunomodulatory effects. Preclinical and translational studies indicate that selective activation of CB2 receptors may attenuate atherogenesis, limit infarct size in ischemia–reperfusion injury, decrease oxidative stress, and lessen chronic inflammation, while avoiding the psychotropic effects linked to CB1. CBD also acts on multiple molecular targets beyond the CB receptors, affecting redox-sensitive transcription factors, vascular tone, immune function, and endothelial integrity. Early clinical trials and observational studies suggest that CBD may lower blood pressure, improve endothelial function, and reduce sympatho-excitatory peptides such as catestatin, with a favorable safety profile. However, limited bioavailability, small sample sizes, short study durations, and uncertainty about long-term safety present challenges to its clinical use. Further research is needed to standardize dosing, refine receptor targeting, and clarify the role of the endocannabinoid system in cardiovascular health. Overall, current evidence supports CBD’s promise as an adjunct in CVD treatment, but broader clinical use requires more rigorous, large-scale studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Hospital of Split, 21000 Split, Croatia.
- Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia.
- Laboratory for Cardiometabolic Research, University of Split School of Medicine, 21000 Split, Croatia.
- Clinical Department of Diagnostic and Interventional Radiology, University Hospital of Split, 21000 Split, Croatia.
- Department of Integrative Physiology, University of Split School of Medicine, 21000 Split, Croatia.
ORCID-Profile: Marko Kumrić, Nikola Pavlović, Joško Božić
Zitieren
APA
Urlić, H., Kumrić, M., Pavlović, N., Dujić, G., Dujić, Ž., & Božić, J. (2025). Cardiovascular Effects of Cannabidiol: From Molecular Mechanisms to Clinical Implementation. International Journal of Molecular Sciences, 26(19), 9610. https://doi.org/10.3390/ijms26199610
Vancouver
Urlić H, Kumrić M, Pavlović N, Dujić G, Dujić Ž, Božić J. Cardiovascular Effects of Cannabidiol: From Molecular Mechanisms to Clinical Implementation. International Journal of Molecular Sciences. 2025;26(19):9610. doi:10.3390/ijms26199610
BibTeX
@article{Urli2025,
author = {Urlić, Hrvoje and Kumrić, Marko and Pavlović, Nikola and Dujić, Goran and Dujić, Željko and Božić, Joško},
title = {Cardiovascular Effects of Cannabidiol: From Molecular Mechanisms to Clinical Implementation},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9610},
doi = {10.3390/ijms26199610}
}
EUVIMED